{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T18:26:56Z","timestamp":1768588016831,"version":"3.49.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Heart Fail Rep"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1007\/s11897-008-0024-y","type":"journal-article","created":{"date-parts":[[2008,10,15]],"date-time":"2008-10-15T03:15:59Z","timestamp":1224040559000},"page":"153-162","source":"Crossref","is-referenced-by-count":14,"title":["Rational use of diuretics in acute decompensated heart failure"],"prefix":"10.1007","volume":"5","author":[{"given":"Jason A.","family":"Goebel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian B.","family":"Van Bakel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,10,16]]},"reference":[{"key":"24_CR1","unstructured":"American Heart Association, American Stroke Association: Heart Disease and Stroke Statistics\u20142008 Update. Available at http:\/\/www.americanheart.org\/downloadable\/heart\/1200078608862HS_Stats%202008.final.pdf . Accessed July 21, 2008."},{"issue":"Suppl7","key":"24_CR2","first-page":"S21","volume":"4","author":"G.C. Fonarow","year":"2003","unstructured":"Fonarow GC, Acute Decompensated Heart Failure National Registry (ADHERE) Advisory Committee: The Acute Decompensated Heart Failure National Registry (ADHERE): opportunities to improve care of patients hospitalized with acute decompensated heart failure. Rev Cardiovasc Med 2003, 4(Suppl 7):S21\u2013S30.","journal-title":"Rev Cardiovasc Med"},{"key":"24_CR3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1056\/NEJM199808063390607","volume":"339","author":"D.C. Brater","year":"1998","unstructured":"Brater DC: Diuretic therapy. N Engl J Med 1998, 339:387\u2013395.","journal-title":"N Engl J Med"},{"key":"24_CR4","first-page":"253","volume-title":"The In Vivo Study of Drug Action: Principles and Applications of Kinetic-Dynamic Modeling","author":"D.C. Brater","year":"1992","unstructured":"Brater DC: Diuretic pharmacokinetics and pharmacodynamics. In The In Vivo Study of Drug Action: Principles and Applications of Kinetic-Dynamic Modeling. Edited by van Boxtel CJ, Holford NHG, Danhof M. Amsterdam: Elsevier Science; 1992:253\u2013275."},{"issue":"12Suppl1","key":"24_CR5","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.amjmed.2006.09.014","volume":"119","author":"J.G.F. Cleland","year":"2006","unstructured":"Cleland JGF, Coletta A, Witte K: Practical applications of intravenous diuretic therapy in decompensated heart failure. Am J Med 2006, 119(12 Suppl 1):S26\u2013S36.","journal-title":"Am J Med"},{"key":"24_CR6","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/ki.1987.246","volume":"32","author":"J.R. Voelker","year":"1987","unstructured":"Voelker JR, Cartwright-Brown D, Anderson S, et al.: Comparison of loop diuretics in patients with chronic renal insufficiency. Kidney Int 1987, 32:572\u2013578.","journal-title":"Kidney Int"},{"key":"24_CR7","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/00005344-199509000-00008","volume":"26","author":"H. Knauf","year":"1995","unstructured":"Knauf H, Mutschler E: Diuretic effectiveness of hydrochlorothiazide and furosemide alone and in combination in chronic renal failure. J Cardiovasc Pharmacol 1995, 26:394\u2013400.","journal-title":"J Cardiovasc Pharmacol"},{"key":"24_CR8","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000047397","volume":"96","author":"D.H. Ellison","year":"2001","unstructured":"Ellison DH: Diuretic therapy and resistance in congestive heart failure. Cardiology 2001, 96:132\u2013143.","journal-title":"Cardiology"},{"key":"24_CR9","first-page":"F1256","volume":"255","author":"B. Kaissling","year":"1988","unstructured":"Kaissling B, Stanton BA: Adaptation of distal tubule and collecting duct to increased sodium delivery. I. Ultrastructure. Am J Physiol 1988, 255:F1256\u2013F1268.","journal-title":"Am J Physiol"},{"key":"24_CR10","doi-asserted-by":"crossref","first-page":"F11","DOI":"10.1152\/ajprenal.00119.2002","volume":"284","author":"S.S. Shankar","year":"2003","unstructured":"Shankar SS, Brater DC: Loop diuretics: from the Na-K-2Cl transporter to clinical use. Am J Physiol Renal Physiol 2003, 284:F11\u2013F21.","journal-title":"Am J Physiol Renal Physiol"},{"key":"24_CR11","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1093\/oxfordjournals.eurheartj.a014805","volume":"17","author":"T.P. Dormans","year":"1996","unstructured":"Dormans TP, Gerlag PG: Combination of high dose furosemide and hydrochlorothiazide in the treatment of refractory heart failure. Eur Heart J 1996, 17:1867\u20131874.","journal-title":"Eur Heart J"},{"key":"24_CR12","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/0735-1097(96)00161-1","volume":"28","author":"T.P. Dormans","year":"1996","unstructured":"Dormans TP, van Meyel JJ, Gerlag PG, et al.: Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion. J Am Coll Cardiol 1996, 28:376\u2013382.","journal-title":"J Am Coll Cardiol"},{"key":"24_CR13","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3109\/00365519709099409","volume":"57","author":"E. Aaser","year":"1997","unstructured":"Aaser E, Gullestad L, Tollofsrud S, et al.: Effect of bolus injection versus continuous infusion of furosemide on diuresis and neurohormonal activation in patients with severe congestive heart failure. Scand J Clin Lab Invest 1997, 57:361\u2013367.","journal-title":"Scand J Clin Lab Invest"},{"key":"24_CR14","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00129804-200407000-00011","volume":"27","author":"M. Mojtahedzadeh","year":"2004","unstructured":"Mojtahedzadeh M, Salehifar E, Vazin A, et al.: Comparison of hemodynamic and biochemical effects of furosemide by continuous infusion and intermittent bolus in critically ill patients. J Infus Nurs 2004, 27:255\u2013261.","journal-title":"J Infus Nurs"},{"key":"24_CR15","doi-asserted-by":"crossref","unstructured":"Salvador DR, Rey NR, Ramos GC, et al.: Continuous infusion versus bolus injection of loop diuretics in congestive heart failure. Cochrane Database Syst Rev 2005, 3:CD003178.","DOI":"10.1002\/14651858.CD003178.pub3"},{"key":"24_CR16","first-page":"F1269","volume":"255","author":"B.A. Stanton","year":"1988","unstructured":"Stanton BA, Kaissling B: Adaptation of distal collecting duct to increased sodium delivery. Am J Physiol 1988, 255:F1269\u2013F1275.","journal-title":"Am J Physiol"},{"key":"24_CR17","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/ki.1994.298","volume":"46","author":"D. Fliser","year":"1994","unstructured":"Fliser D, Schr\u00f6ter M, Neubeck M, et al.: Coadministration of thiazides increases the efficacy of loop diuretics even in patients with advanced renal failure. Kidney Int 1994, 46:482\u2013488.","journal-title":"Kidney Int"},{"key":"24_CR18","doi-asserted-by":"crossref","first-page":"405","DOI":"10.7326\/0003-4819-99-3-405","volume":"99","author":"J.R. Oster","year":"1983","unstructured":"Oster JR, Epstein M, Smoller S: Combined therapy with thiazide type and loop diuretic agents for resistant sodium retention. Ann Intern Med 1983, 99:405\u2013406.","journal-title":"Ann Intern Med"},{"key":"24_CR19","first-page":"656","volume":"21","author":"M. Epstein","year":"1977","unstructured":"Epstein M, Lepp BA, Hoffman DS, et al.: Potentiation of furosemide by metolazone in refractory edema. Curr Ther Res 1977, 21:656\u2013667.","journal-title":"Curr Ther Res"},{"key":"24_CR20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1067\/mhj.2002.123144","volume":"144","author":"G.W. Neuberg","year":"2002","unstructured":"Neuberg GW, Miller AB, O\u2019Connor CM, et al.: Diuretic resistance predicts mortality in patients with advanced heart failure (Prospective Randomized Amlodipine Survival Evaluation). Am Heart J 2002, 144:31\u201338.","journal-title":"Am Heart J"},{"key":"24_CR21","doi-asserted-by":"crossref","unstructured":"The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V) [no authors listed]. Arch Intern Med 1993, 153:154\u2013183.","DOI":"10.1001\/archinte.1993.00410020010002"},{"key":"24_CR22","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1161\/01.CIR.100.12.1311","volume":"100","author":"H.A. Cooper","year":"1999","unstructured":"Cooper HA, Dries DL, Davis CE, et al.: Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction. Circulation 1999, 100:1311\u20131315.","journal-title":"Circulation"},{"key":"24_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-103-1-1","volume":"103","author":"G.S. Francis","year":"1985","unstructured":"Francis GS, Siegel RM, Goldsmith SR, et al.: Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohormonal axis. Ann Intern Med 1985, 103:1\u20136.","journal-title":"Ann Intern Med"},{"issue":"SupplD","key":"24_CR24","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/eurheartj\/11.suppl_D.44","volume":"11","author":"M. Packer","year":"1990","unstructured":"Packer M: Why do the kidneys release renin in patients with congestive heart failure? A nephrocentric view of converting-enzyme inhibition. Eur Heart J 1990, 11(Suppl D):44\u201352.","journal-title":"Eur Heart J"},{"key":"24_CR25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2125.1984.tb05024.x","volume":"18","author":"G.D. Johnston","year":"1984","unstructured":"Johnston GD, Nicholls DP, Leahey WJ: The dose-response characteristics of the acute non-diuretic peripheral vascular effects of furosemide in normal subjects. Br J Clin Pharmacol 1984, 18:75\u201381.","journal-title":"Br J Clin Pharmacol"},{"key":"24_CR26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/hrt.57.1.17","volume":"57","author":"J. Bayliss","year":"1987","unstructured":"Bayliss J, Norell M, Canepa-Anson R, et al.: Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics. Br Heart J 1987, 57:17\u201322.","journal-title":"Br Heart J"},{"issue":"SupplA","key":"24_CR27","doi-asserted-by":"crossref","first-page":"146A","DOI":"10.1016\/0735-1097(93)90480-O","volume":"22","author":"C.R. Benedict","year":"1993","unstructured":"Benedict CR, Weiner DH, Johnstone DE, et al.: Comparative neurohormonal responses in patients with preserved and impaired left ventricular ejection fraction: results of the Studies of Left Ventricular Dysfunction (SOLVD) registry. The SOLVD Investigators. J Am Coll Cardiol 1993, 22(Suppl A):146A\u2013153A.","journal-title":"J Am Coll Cardiol"},{"key":"24_CR28","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/0002-9149(82)90243-0","volume":"49","author":"T.B. Levine","year":"1982","unstructured":"Levine TB, Francis GS, Goldsmith SR, et al.: Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. Am J Cardiol 1982, 49:1659\u20131666.","journal-title":"Am J Cardiol"},{"key":"24_CR29","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"10","author":"B. Pitt","year":"1999","unstructured":"Pitt B, Zannad F, Remme WJ, et al.: The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999, 10:709\u2013717.","journal-title":"N Engl J Med"},{"key":"24_CR30","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1161\/01.CIR.83.6.1849","volume":"83","author":"K.T. Weber","year":"1991","unstructured":"Weber KT, Brilla CG: Pathological hypertrophy and the cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation 1991, 83:1849\u20131865.","journal-title":"Circulation"},{"key":"24_CR31","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1161\/01.RES.67.6.1355","volume":"67","author":"C.G. Brilla","year":"1990","unstructured":"Brilla CG, Pick R, Tan LB, et al.: Remodeling of the rat right and left ventricles in experimental hypertension. Circ Res 1990, 67:1355\u20131364.","journal-title":"Circ Res"},{"key":"24_CR32","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1161\/01.HYP.31.1.451","volume":"31","author":"R. Rocha","year":"1998","unstructured":"Rocha R, Chander PN, Khanna K, et al.: Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats. Hypertension 1998, 31:451\u2013458.","journal-title":"Hypertension"},{"key":"24_CR33","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1161\/01.HYP.24.5.571","volume":"24","author":"W. Wang","year":"1994","unstructured":"Wang W: Chronic administration of aldosterone depresses baroreceptor reflex function in the dog. Hypertension 1994, 24:571\u2013575.","journal-title":"Hypertension"},{"key":"24_CR34","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1071-9164(96)80009-1","volume":"2","author":"A.D. Struthers","year":"1996","unstructured":"Struthers AD: Aldosterone escape during angiotensinconverting enzyme inhibitor therapy in chronic heart failure. J Card Fail 1996, 2:47\u201354.","journal-title":"J Card Fail"},{"key":"24_CR35","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ahj.2003.08.012","volume":"147","author":"J. Butler","year":"2004","unstructured":"Butler J, Forman DE, Abraham WT, et al.: Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart J 2004, 147:331\u2013338.","journal-title":"Am Heart J"},{"key":"24_CR36","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jacc.2003.07.031","volume":"43","author":"D.E. Forman","year":"2004","unstructured":"Forman DE, Butler J, Wang Y, et al.: Incidence, predicators at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol 2004, 43:62\u201367.","journal-title":"J Am Coll Cardiol"},{"key":"24_CR37","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0002-8703(99)70009-8","volume":"138","author":"E.L. Knight","year":"1999","unstructured":"Knight EL, Glynn RJ, McIntyre KM, et al.: Predictors of decreased renal function with heart failure during ACE-I therapy: results from studies of left ventricular function (SOLVD). Am Heart J 1999, 138:849\u2013855.","journal-title":"Am Heart J"},{"key":"24_CR38","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.jacc.2007.08.072","volume":"51","author":"A. Nohria","year":"2008","unstructured":"Nohria A, Haselblad V, Stebbins A, et al.: Cardiorenal interactions: insight from the ESCAPE trial. J Am Coll Cardiol 2008, 51:1268\u20131274.","journal-title":"J Am Coll Cardiol"},{"key":"24_CR39","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1053\/ejvs.2002.1930","volume":"26","author":"V. Papavassiliou","year":"2003","unstructured":"Papavassiliou V, Anderton M, Loftus IM, et al.: The physiological effects of elevated intra-abdominal pressure following aneurysm repair. Eur J Vas Endovasc Surg 2003, 26:293\u2013298","journal-title":"Eur J Vas Endovasc Surg"},{"key":"24_CR40","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.ejheart.2007.05.010","volume":"9","author":"K. Damman","year":"2007","unstructured":"Damman K, Navis G, Smilde TDJ, et al.: Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction. Eur J Heart Fail 2007, 9:872\u2013878","journal-title":"Eur J Heart Fail"},{"issue":"Suppl1","key":"24_CR41","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1097\/01.CCM.0000296270.41256.5C","volume":"36","author":"K.V. Liang","year":"2008","unstructured":"Liang KV, Williams AW, Green EL, et al.: Acute decompensated heart failure and the cardiorenal syndrome. Crit Care Med 2008, 36(Suppl 1):S75\u2013S88.","journal-title":"Crit Care Med"},{"key":"24_CR42","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0140-6736(97)08417-1","volume":"351","author":"G. Cotter","year":"1998","unstructured":"Cotter G, Metzkor E, Kaluski E, et al.: Randomized trial of high-dose isosorbide dinitrate plus low dose furosemide versus high dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary edema. Lancet 1998, 351:389\u2013393.","journal-title":"Lancet"},{"key":"24_CR43","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0735-1097(02)01814-4","volume":"39","author":"W. Johnson","year":"2002","unstructured":"Johnson W, Omland T, Hall C, et al.: Neurohormonal activation rapidly decreases after intravenous therapy with diuretics and vasodilators for class IV heart failure. J Am Coll Cardiol 2002, 39:1623\u20131629.","journal-title":"J Am Coll Cardiol"},{"key":"24_CR44","first-page":"1531","volume":"287","author":"The Vasodilation in the Management of Acute Congestive Heart Failure","year":"2002","unstructured":"The Vasodilation in the Management of Acute Congestive Heart Failure (VMAC) Investigators: Intravenous nesiritide versus nitroglycerin for treatment of decompensated congestive heart failure. JAMA 2002, 287:1531\u20131540.","journal-title":"JAMA"},{"key":"24_CR45","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1161\/01.CIR.0000159340.93220.E4","volume":"111","author":"J.D. Sackler-Bernstein","year":"2005","unstructured":"Sackler-Bernstein JD, Skopicki HA, Aaronson KD: Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation 2005, 111:1487\u20131491.","journal-title":"Circulation"},{"key":"24_CR46","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.cardfail.2007.12.002","volume":"14","author":"T.E. Owan","year":"2008","unstructured":"Owan TE, Chen HH, Frantz RP, et al.: The effects of nesiritide on renal function and diuretic responsiveness in acutely decompensated heart failure patients with renal dysfunction. J Card Fail 2008, 14:267\u2013275.","journal-title":"J Card Fail"},{"key":"24_CR47","doi-asserted-by":"crossref","first-page":"H261","DOI":"10.1152\/ajpcell.1988.255.4.C536","volume":"255","author":"B.R. Walker","year":"1988","unstructured":"Walker BR, Childs ME, Adams EM: Direct cardiac effects of vasopressin: the role of V1 and V2 vasopressinergic receptors. Am J Physiol 1988, 255:H261\u2013H265.","journal-title":"Am J Physiol"},{"key":"24_CR48","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1001\/jama.297.12.1332","volume":"297","author":"M. Gheorghiade","year":"2007","unstructured":"Gheorghiade M, Konstam MA, Burnett JC Jr, et al.: Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials. JAMA 2007, 297:1332\u20131343.","journal-title":"JAMA"},{"key":"24_CR49","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jama.297.12.1319","volume":"297","author":"M.A. Konstam","year":"2007","unstructured":"Konstam MA, Gheorghiade M, Burnett JC Jr, et al.: Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA 2007, 297:1319\u20131331.","journal-title":"JAMA"},{"key":"24_CR50","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ejheart.2008.01.010","volume":"10","author":"V. Vallon","year":"2008","unstructured":"Vallon V, Miracle C, Thompson S: Adenosine and kidney function: potential implications in patients with heart failure. Eur J Heart Fail 2008, 10:176\u2013187.","journal-title":"Eur J Heart Fail"},{"key":"24_CR51","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0735-1097(99)00532-X","volume":"35","author":"S.S. Gottlieb","year":"2000","unstructured":"Gottlieb SS, Skettino SL, Wolff A, et al.: Effects of BG9719 (CVT-124), an A1-adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure. J Am Coll Cardiol 2000, 35:56\u201359.","journal-title":"J Am Coll Cardiol"},{"key":"24_CR52","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1161\/hc1102.105264","volume":"105","author":"S.S. Gottlieb","year":"2002","unstructured":"Gottlieb SS, Brater DC, Thomas I, et al.: Effects of BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy. Circulation 2002, 105:1348\u20131353.","journal-title":"Circulation"},{"key":"24_CR53","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.jacc.2007.07.019","volume":"50","author":"M.M. Givertz","year":"2007","unstructured":"Givertz MM, Massie BM, Fields TK, et al.: The effects of KW-3902, an adenosine A1-receptor antagonist, on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance. J Am Coll Cardiol 2007, 50:1551\u20131560.","journal-title":"J Am Coll Cardiol"},{"key":"24_CR54","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.cardfail.2007.08.006","volume":"13","author":"H.C. Dittrich","year":"2007","unstructured":"Dittrich HC, Gupta DK, Hack TC, et al.: The effect of KW-3902, an adenosine A1 receptor antagonist, on renal function and plasma flow in ambulatory patients with heart failure and renal impairment. J Card Fail 2007, 13:609\u2013617.","journal-title":"J Card Fail"},{"key":"24_CR55","doi-asserted-by":"crossref","first-page":"21A","DOI":"10.1016\/0002-9149(93)90241-4","volume":"71","author":"A.A. Vliet van","year":"1993","unstructured":"van Vliet AA, Donker AJM, Nauta JJ, et al.: Spironolactone in congestive heart failure refractory to high-dose loop diuretic and low-dose angiotensin-converting enzyme inhibitor. Am J Cardiol 1993, 71:21A\u201328A.","journal-title":"Am J Cardiol"},{"key":"24_CR56","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0022-4804(90)90174-Z","volume":"49","author":"U. Kreimeir","year":"1990","unstructured":"Kreimeir U, Bruckner UB, Schmidt J, et al.: Instantaneous restoration of regional organ blood flow after severe hemorrhage: effect of small volume resuscitation with hypertonic-hyperoncotic solutions. J Surg Res 1990, 49:493\u2013503.","journal-title":"J Surg Res"},{"key":"24_CR57","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1067\/mhj.2003.166","volume":"145","author":"G. Licata","year":"2003","unstructured":"Licata G, Di Pasquale P, Parrinello G, et al.: Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus in refractory congestive heart failure: long-term effects. Am Heart J 2003, 145:459\u2013466.","journal-title":"Am Heart J"},{"key":"24_CR58","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1161\/01.CIR.102.2.203","volume":"102","author":"H.L. Hillege","year":"2000","unstructured":"Hillege HL, Girbes AR, de Kam PJ, et al.: Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 2000, 102:203\u2013210.","journal-title":"Circulation"},{"key":"24_CR59","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/hrt.72.6.534","volume":"72","author":"M.D. Guazzi","year":"1994","unstructured":"Guazzi MD, Agostoni P, Perego G, et al.: Apparent paradox of neurohormonal axis inhibition after body fluid volume depletion in patients with chronic congestive heart failure and water retention. Br Heart J 1994, 72:534\u2013539.","journal-title":"Br Heart J"},{"key":"24_CR60","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jacc.2006.07.073","volume":"49","author":"M.R. Costanzo","year":"2007","unstructured":"Costanzo MR, Guglin ME, Saltzberg MT, et al.: Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 2007, 49:675\u2013683.","journal-title":"J Am Coll Cardiol"},{"key":"24_CR61","unstructured":"Klabunde RD: Cardiovascular pharmacology concepts. Available at http:\/\/www.cvpharmacology.com\/diuretic\/diuretics.htm . Accessed July 21, 2008."}],"container-title":["Current Heart Failure Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11897-008-0024-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11897-008-0024-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11897-008-0024-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T20:09:50Z","timestamp":1559419790000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11897-008-0024-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["24"],"URL":"https:\/\/doi.org\/10.1007\/s11897-008-0024-y","relation":{},"ISSN":["1546-9530","1546-9549"],"issn-type":[{"value":"1546-9530","type":"print"},{"value":"1546-9549","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}